J. J. Moreau-de-tours, Du hachisch et de l'aliénation mentale, études psychologiques

L. Nezet and O. , Drogues et addictions, les données essentielles. 112, 2013.

, Observatoire Français des Drogues et Toxicomanies

T. J. Crowley, M. J. Macdonald, E. A. Whitmore, and S. K. Mikulich, Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. Drug and alcohol dependence, vol.50, pp.27-37, 1998.

W. Pedersen, Adolescents initiating cannabis use : cultural opposition or poor mental health, Journal of adolescence, vol.13, issue.4, pp.327-339, 1990.

H. Szutorisz and Y. L. Hurd, Epigenetic effects of cannabis exposure, Biological psychiatry, vol.79, issue.7, pp.586-594, 2016.

H. Chabrol, E. Chauchard, N. Goutaudier, and N. Van-leeuwen, Exploratory study of the psychopathological profiles of adolescent cannabis users, Addictive behaviors, vol.37, issue.10, pp.1109-1113, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02351142

M. Reynaud and A. Benyamina, Addiction au cannabis. Editions Flammarion, 2001.

, Observatoire Français des Drogues et Toxicomanies, pp.31-2019

, Observatoire Français des Drogues et Toxicomanies, pp.31-2019

, Observatoire Français des Drogues et Toxicomanies, pp.31-2019

F. Beck, S. Spilka, V. Nguyen-thanh, A. Gautier, L. Nézet et al., Cannabis : usage actuels en population adulte, Tendances, vol.119, pp.1-4, 2017.

M. Reynaud and A. Benyamina, Addiction au cannabis. Editions Flammarion, p.11, 2009.

M. Reynaud and A. Benyamina, Addiction au cannabis. Editions Flammarion, p.16, 2009.

, Observatoire Français des Drogues et Toxicomanies

, Observatoire européen des drogues et toxicomanies. Rapport européen sur les drogues, tendances et évolution, 2018.

W. Pedersen, A. Mastekaasa, and L. Wichstrøm, Conduct problems and early cannabis initiation : a longitudinal study of gender differences, Addiction, vol.96, issue.3, pp.415-431, 2001.

, National Institut of Drug Abuse

L. D. Johnston, R. A. Miech, P. M. O'malley, J. G. Bachman, J. E. Schulenberg et al., Monitoring the future, national survey results on drug use, 1975.

, Organisation Mondiale de la Santé

C. Coffey, J. B. Carlin, L. Degenhardt, M. Lynskey, L. Sanci et al., Cannabis dependence in young adults : an Australian population study, Addiction, vol.97, issue.2, pp.187-194, 2002.

J. M. Boden, D. M. Fergusson, and L. J. Horwood, Illicit drug use and dependence in a New Zealand birth cohort. The Australian and New Zealand journal of psychiatry, vol.40, pp.156-163, 2006.

D. Kandel, K. Chen, L. A. Warner, R. C. Kessler, and B. Grant, Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. population. Drug and alcohol dependence, vol.44, pp.11-29, 1997.

K. Chen, D. B. Kandel, and M. Davies, Relationships between frequency and quantity of marijuana use and last year proxy dependence among adolescents and adults in the Unites States. Drug and alcohol dependence, vol.46, pp.53-67, 1997.

B. F. Grant and R. Pickering, The relationship between cannabis use and DSM-IV cannabis abuse and dependance : results from the National Longitudinal Alcohol Epidemiologic Survey, Journal of substance abuse, vol.10, issue.3, pp.255-264, 1998.

W. M. Compton, B. F. Grant, J. D. Colliver, M. D. Glantz, and F. S. Stinson, Prevalence of marijuana use disorders in the United States, JAMA, vol.291, issue.17, pp.2114-2121, 1991.

A. Perkonigg, R. D. Goodwin, A. Fiedler, S. Behrendt, K. Beesdo et al., The natural course of cannabis use, abuse and dependence during the first decades of life, Addiction, vol.103, issue.3, pp.439-449, 2008.

H. Chabrol, N. Fredaigue, and S. Callahan, Epidemiological study of cannabis abuse and dependence in 256 adolescents, L'Encephale, vol.26, issue.4, pp.47-49, 2000.

M. Reynaud and A. Benyamina, Addiction au cannabis. Editions Flammarion, p.51, 2009.

M. Reynaud and A. Benyamina,

, DSM-5 : manuel diagnostique et statistique des troubles mentaux, American Psychiatric Association, 2015.

C. Demily and N. Franck, Schizophrénie : diagnostic et prise en charge, pp.21-23, 2013.

A. S. Brown, M. D. Begg, S. Gravenstein, C. A. Schaefer, R. J. Wyatt et al., , 2004.

, Serologic evidence of prenatal influenza in etiology of schizophrenia, Archives of general psychiatry, issue.8, pp.774-780

P. Abdelmalik, J. Husted, E. W. Chow, and A. S. Bassett, Childhood head injury and expression of schizophrenia in multiply affected families, Archives of general psychiatry, vol.60, issue.3, pp.231-236, 2003.

S. L. Matheson, A. M. Sheperd, K. R. Laurens, and V. J. Carr, A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia, Schizophrenia research, vol.133, issue.1-3, pp.133-142, 2011.

T. J. Ekström, C. Lavebratt, and M. Schalling, The importance of epigenomic studies in schizophrenia, Epigenomics, vol.4, issue.4, pp.359-362, 2012.

J. C. Simeone, A. J. Ward, P. Rotella, J. Collins, and R. Windisch, An evaluation of variation in published estimates of schizophrenia prevalence from 1990-2013 : a systematic literature review, BMC Psychiatry, vol.15, p.193, 2015.

S. Andreasson, A. Engstrom, P. Allebeck, and U. Rydberg, Cannabis and schizophrenia : a longitudinal study of Swedish conscripts, The Lancet, vol.330, pp.1483-1486, 1987.

W. Hall and L. Degenhardt, Cannabis use and psychosis : a review of clinical and epidemiological evidence. The Australian and New Zealand journal of psychiatry, vol.34, pp.26-34, 2000.

J. Van-os, M. Bak, M. Hanssen, R. V. Bijl, R. De-graaf et al., Cannabis use and psychosis : a longitudinal population-based study, American journal of epidemiology, vol.156, issue.4, pp.319-327, 2002.

O. Krebs, Est-il possible d'établir un lien de causalité entre de substances psycho-actives et schizophrénie débutante ?, dans Schizophrénies débutantes : diagnostic et modalités thérapeutiques de F. Petitjean et M. Marie-Cardine, 2003.

C. Henquet, L. Krabbendam, J. Spauwen, C. Kplan, R. Lieb et al., , 2005.

, Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people, BMJ, vol.330, issue.7481

L. Arsenault, M. Cannon, R. Poulton, R. Murray, A. Caspi et al., Cannabis use in adolescence and risk for adult psychosis : longitudinal prospective study, BMJ, vol.325, issue.7374, pp.1212-1213, 2002.

D. A. Regier, M. E. Farmer, D. S. Rae, B. Z. Locke, S. J. Keith et al., Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study, JAMA, vol.264, issue.19, pp.2511-2518, 1990.

D. M. Ziedonis, D. Smelson, R. N. Rosenthal, S. L. Batki, A. I. Green et al., Improving the care of individuals with schizophrenia and substance use disorders : consensus recommendations, Journal of psychiatric practice, vol.11, issue.5, pp.315-339, 2005.

G. Carrà, S. Johnson, P. Bebbington, M. C. Angermeyer, D. Heider et al., The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe : findings from the European Schizophrenia Cohort (EuroSC). European archives of psychiatry and clinical neuroscience, vol.262, pp.607-616, 2012.

J. Koskinen, J. Löhönen, H. Koponen, M. Isohanni, and J. Miettunen, Rate of cannabis use disorders in clinical samples of patients with schizophrenia : a meta-analysis, Schizophrenia bulletin, vol.36, issue.6, pp.1115-1130, 2010.

R. A. Rabin, K. K. Zakzanis, Z. J. Daskalakis, and T. P. George, Effects of cannabis use status on cognitive function, in males with schizophrenia, Psychiatry research, vol.206, issue.2-3, pp.158-165, 2013.

A. Dervaux, X. Laqueille, M. C. Bourdel, M. H. Leborgne, J. P. Olie et al., Cannabis and schizophrenia : demographic and clinical correlates, L'Encéphale, vol.29, issue.1, pp.11-17, 2003.

A. Johns, Psychiatric effects of cannabis. The British journal of psychiatry : the journal of mental science, vol.178, pp.116-122, 2001.

L. Dixon, Dual diagnosis of substance abuse in schizophrenia : prevalence and impact on outcomes, Schizophrenia Research, vol.35, pp.93-100, 1999.

M. Hambrecht and H. Häfner, Substance abuse and the onset of schizophrenia, Biological psychiatry, vol.40, issue.11, pp.1155-1163, 1996.

J. A. Niemi-pynttäri, R. Sund, H. Putkonen, H. Vorma, K. Wahlbeck et al., , 2013.

, Substance-induced psychoses converting into schizophrenia : a register-based study, vol.18, p.478

, Finnish inpatient cases, The Journal of clinical psychiatry, vol.74, issue.1, pp.94-99

M. Reynaud and A. Benyamina, Addiction au cannabis. Editions Flammarion, p.61, 2009.

M. J. Martinez-arevalo, A. Calcedo-ordoñez, and J. R. Varo-prieto, Cannabis comsuptions as a prognostic factor in schizophrenia. The British journal of psychiatry : the journal of mental science, vol.164, p.131, 1994.

F. Liraud and H. Veroud, Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders, vol.28, pp.160-168, 2002.

P. Allebeck, C. Adamsson, A. Engström, and U. Rydberg, Cannabis and schizophrenia : a longitudinal study of cases treated in Stockholm County, Acta Psychiatrica Scandinavica, vol.88, issue.1, pp.21-24, 1993.

V. Peralta and M. J. Cuesta, Influence of cannabis abuse on schizophrenic psychopathology, 1992.

, Acta Psychiatrica Scandinavica, vol.85, issue.2, pp.127-130

D. H. Linszen, P. M. Dingemans, and M. E. Lenior, Cannabis abuse and the course of recentonset schizophrenic disorders, Archives of general psychiatry, vol.51, issue.4, pp.273-279, 1994.

G. Bersani, V. Orlandi, G. D. Kotzalidis, and P. Pancheri, Cannabis and schizophrenia : impact on onset, course, psychopathology and outcomes. European archives of psychiatry and clinical neuroscience, vol.252, pp.86-92, 2002.

M. O. Krebs, S. Leroy, E. Duaux, and M. C. Bourdel, Vulnerability to cannabis, schizophrenia and the (ATT)n polymorphism of the cannabinoid receptor type I (CNR1) gene, Schizophrenia Research, vol.53, issue.3, pp.72-72, 2002.

M. Rais, W. Cahn, N. Van-haren, H. Schnack, E. Caspers et al., , 2008.

, Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients

, The American journal of psychiatry, vol.165, issue.4, pp.490-496

K. T. Mueser, P. R. Arnold, and A. S. Bellack, Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder, Acta Psychiatrica Scandinavica, vol.85, issue.1, pp.48-55, 1992.

M. Soyka, M. Albus, N. Kathmann, A. Finelli, S. Hofstetter et al., , 1993.

, European archives of psychiatry and clinical neuroscience, vol.242, pp.362-372

M. Reynaud and A. Benyamina, Addiction au cannabis. Editions Flammarion, p.65, 2009.

M. R. Tramèr, D. Carroll, F. A. Campbell, D. J. Reynolds, R. A. Moore et al., , 2001.

, Cannabinoids for control of chemotherapy induced nausea and vomiting : quantitative systematic review, BMJ, vol.323, issue.7303, pp.16-21

D. C. D'souza, E. Perry, L. Macdougall, Y. Ammerman, T. Cooper et al., The psychomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals : implications for psychosis, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, vol.29, issue.8, 2004.

H. Verdoux, F. Sorbara, C. Gindre, J. D. Swendsen, and J. Van-os, Cannabis use and dimensions of psychosis in a nonclinical population of female subjects, Schizophrenia research, vol.59, issue.1, pp.77-84, 2003.

V. Ajdacic-gross, C. Lauber, I. Warnke, H. Haker, R. M. Murray et al., Changing incidence of psychotic disorders among the young in Zurich, Schizophrenia research, vol.95, issue.1-3, pp.9-18, 2007.

C. Goldberger, A. Dervaux, D. Gourion, M. C. Bourdel, H. Lôo et al., Variable individuel sensitivity to cannabis in patients with schizophrenia, The international journal of neuropsychopharmacology, vol.13, issue.9, pp.1145-1154, 2010.

L. Degenhardt, W. Hall, and M. Lynskey, Testing hypotheses about the relationship between cannabis use and psychosis. Drug and alcohol dependence, vol.71, pp.37-48, 2003.

A. Benyamina, Congrès de psychiatrie et de neurologie de langue française, 0216.

J. Palazzolo and L. Raure, , 2005.

G. Bonnier and G. De-layens, Flore complète portative de la France, de la Suisse et de la Belgique, vol.284, 2011.

J. L. Richard-d-et-senon and . Le, Edition Presses universitaires de France, 2010.

J. L. Richard-d-et-senon and . Le, Edition Presses universitaires de France, p.10, 2010.

J. L. Richard-d-et-senon and . Le, Edition Presses universitaires de France, 2010.

, PubChem National for Biotechnology Information, issue.8, 2018.

, PubChem National for Biotechnology Information, issue.8, 2018.

, PubChem National for Biotechnology Information, issue.8, 2018.

J. L. Richard-d-et-senon and . Le, Edition Presses universitaires de France, p.14, 2010.

J. L. Richard-d-et-senon and . Le, Edition Presses universitaires de France, p.17, 2010.

J. L. Richard-d-et-senon and . Le, Edition Presses universitaires de France, p.11, 2010.

J. L. Richard-d-et-senon and . Le, Edition Presses universitaires de France, p.12, 2010.

L. Monde, , 2018.

J. L. Richard-d-et-senon and . Le, Edition Presses universitaires de France, p.13, 2010.

E. Enquête, , 2017.

, Observatoire Français des Drogues et Toxicomanies, p.10, 2018.

J. L. Richard-d-et-senon and . Le, Edition Presses universitaires de France, p.18, 2010.

, Observatoire Français des Drogues et Toxicomanies, p.10, 2018.

, Observatoire Français des Drogues et Toxicomanies, p.10, 2018.

J. L. Richard-d-et-senon and . Le, Edition Presses universitaires de France, 1921.

, Observatoire Français des Drogues et Toxicomanies, p.10, 2018.

, Observatoire Français des Drogues et Toxicomanies, p.10, 2018.

. Richard-d, J. L. Senon, and . Le, Edition Presses universitaires de France, p.25, 2010.

. Richard-d, J. L. Senon, and . Le, Edition Presses universitaires de France, p.26, 2010.

M. Sami-ali and . Le-haschich-en-egypte, , 1988.

. Richard-d, J. L. Senon, and . Le, Edition Presses universitaires de France, p.45, 2010.

J. Schou, L. Prockop, G. Dahlström, and C. Rohde, Penetration of delta-9-tetrahydrocannabinol and 11-OH-delta-9-tetrahydrocannabinol through the blood-brain Barrier, 1977.

, Acta Pharmacol Toxicol, vol.41, pp.33-38

M. E. Wall, D. R. Brine, and M. Perez-reyes, The metabolism of Delta9tetrahydrocannabinol, 11 hydroxy-Delta-9-THC and 8beta hydroxy Delta9 THC in man, vol.33, p.258, 1973.

, Cannabis : quels effets sur le comportement et la santé ? I, INSERM. Pharmacocinétique et méthodes de dosage du D9-THC, p.149, 2001.

A. Smith-kielland, B. Skuterud, and J. Morland, Urinary excretion of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users, J Anal Toxicol, vol.23, pp.323-332, 1999.

, Cannabis : quels effets sur le comportement et la santé ? I, INSERM. Pharmacocinétique et méthodes de dosage du D9-THC, p.151, 2001.

. Richard-d, J. L. Senon, and . Le, Edition Presses universitaires de France, p.57, 2010.

, DSM-5 : manuel diagnostique et statistique des troubles mentaux, American Psychiatric Association, p.134, 2015.

T. S. Nawrot, L. Perez, N. Künzli, E. Munters, and B. Nemery, Public health importance of triggers of myocardial infarction : a comparative risk assessment, The Lancet, vol.377, issue.9767, pp.732-740, 2011.

J. Quickfall and D. Crockford, Brain neuroimaging in cannabis use : a review. The journal of neuropsychiatry and neurosciences, vol.18, pp.318-332, 2006.

R. J. Mathew, W. H. Wilson, R. E. Coleman, T. G. Turkington, and T. R. Degrado, Marijuana intoxication and brain activation in marijuana smokers, Life sciences, vol.60, issue.23, pp.2075-2089, 1997.

R. J. Mathew, W. H. Wilson, T. G. Turkington, T. C. Hawk, R. E. Coleman et al., Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography, Psychiatry research, vol.116, issue.3, pp.173-185, 2002.

R. J. Mathew, W. H. Wilson, T. G. Turkington, and R. E. Coleman, Cerebellar activity and disturbed time sense after THC, Brain research, vol.797, issue.2, pp.183-189, 1998.

N. D. Volkow, H. Gillespie, N. Mullani, L. Tancredi, C. Grant et al., , 1991.

, Cerebellar metabolic activation by delta-9-tetrahydro-cannabinol in human brain : a study with positron emission tomography and 18F-2-fluoro-2-deoxyglucose, Psychiatry research, vol.40, issue.1, pp.69-78

W. Bromberg, Marihuana intoxication : a clinical study of Cannabis sativa intoxication. The American journal of psychiatry, vol.91, pp.303-330, 1934.

, Observatoire Français des Drogues et Toxicomanies, p.13, 2018.

M. Reynaud and A. Benyamina, , p.49, 2009.

A. Benyamina, Congrès de psychiatrie et de neurologie de langue française, 0217.

M. Ranganathan and D. C. Souza, The acute effects of cannabinoids on memory in humans : a review, Psychopharmacology, vol.188, issue.4, pp.425-444, 2006.

C. H. Ashton, Pharmacology and effects of cannabis : a brief review. The British journal of psychiatry : the journal of mental science, vol.178, pp.101-106, 2001.

I. Kurzthaler, M. Hummer, C. Miller, B. Sperner-unterweger, V. Günther et al., Effects of cannabis use on cognitive functions and driving ability. The journal of clinical psychiatry, vol.60, pp.395-399, 1999.

L. Dictionnaire,

A. J. Budney, P. L. Novy, and J. R. Hughes, Marijuana withdrawal among adults seeking treatment for marijuana dependance, Addiction, vol.94, issue.9, pp.1311-1322, 1999.

M. Reynaud and A. Benyamina, , 1925.

J. Daléry, T. D'amato, and M. Saoud, , p.12, 2012.

M. Reynaud and A. Benyamina, , p.60, 2009.

D. Richard, J. L. Et-senon, and . Le, Edition Presses universitaires de France, p.68, 2010.

, DSM-5 : manuel diagnostique et statistique des troubles mentaux, Chapitre : spectre de la schizophrénie et autres troubles psychotiques, 2015.

C. Demily and N. Et-franck, Schizophrénie : diagnostic et prise en charge, p.65, 2013.

C. Demily and N. Et-franck, Schizophrénie : diagnostic et prise en charge, pp.56-57, 2013.

C. Demily and N. Et-franck, Schizophrénie : diagnostic et prise en charge, p.131, 2013.

C. Demily and N. Et-franck, Schizophrénie : diagnostic et prise en charge, p.129, 2013.

C. Demily and N. Et-franck, Schizophrénie : diagnostic et prise en charge, p.130, 2013.

, Meddispar, 2018.

. Meddispar, , 2018.

C. Demily and N. Et-franck, Schizophrénie : diagnostic et prise en charge, pp.144-145, 2013.

C. Demily and N. Et-franck, Schizophrénie : diagnostic et prise en charge, pp.146-147, 2013.

M. Reynaud and A. Benyamina, , 1920.

D. Richard, J. L. Et-senon, and . Le, Edition Presses universitaires de France, p.52, 2010.

M. Reynaud and A. Benyamina, , 1922.

M. Reynaud and A. Benyamina, , p.23, 2009.

M. Reynaud and A. Benyamina,

S. R. Laviolette and A. A. Grace, The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits : implications for schizophrenia and addiction. Cellular and molecular life sciences, vol.63, pp.1597-1613, 2006.

E. Schlicker and M. Katzmann, Modulation of transmitter release via presynaptic cannabinoid receptors, Trends in pharmacological sciences, vol.22, issue.11, pp.565-572, 2001.

M. Hajos, W. E. Hoffmann, and B. Kocsis, Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation : relevance to schizophrenia, Biological psychiatry, vol.63, issue.11, pp.1075-1083, 2008.

M. R. Broome, J. B. Woolley, P. Tabraham, L. C. Johns, E. Bramon et al., What causes the onset of psychosis ?, Schizophrenia research, vol.79, issue.1, pp.23-34, 2005.

L. E. Delisi, The effect of cannabis on the brain : can it cause brain anomalies that lead to increased risk for schizophrenia ? Current opinion in psychiatry, vol.21, pp.140-150, 2008.

S. M. Lawrie, A. M. Mcintosh, J. Hall, D. G. Owens, and E. C. Jonhstone, Brain structure and function changes during the development of schizophrenia : the evidence from studies of subjects at increased genetic risk, Schizophrenia bulletin, vol.34, issue.2, pp.330-340, 2008.

F. M. Leweke, A. Giuffrida, D. Koethe, D. Schreiber, B. M. Nolden et al., , 2007.

, Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients : impact of cannabis use, Schizophrenia research, vol.94, issue.1-3, pp.29-36

F. M. Leweke, A. Giuffrida, U. Wurster, H. M. Erich, and D. Piomelli, Elevated endogenous cannabinoids in schizophrenia, Neuroreport, vol.10, issue.8, pp.1665-1669, 1999.

B. Dean, S. Sundram, R. Bradbury, E. Scarr, and D. Copolov, Studies on [3H]CP-55940 binding in the human central nervous system : regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use, Neuroscience, vol.103, issue.1, pp.9-15, 2001.

K. A. Newell, C. Deng, and X. F. Huang, Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia, Experimental brain research, vol.172, issue.4, pp.556-560, 2006.

M. A. Blomfield, A. H. Ashok, N. D. Volkow, and O. D. Howes, The effects of delta-9-tetrahydrocannbinol on the dopamine system, Nature, vol.539, issue.7629, pp.369-377, 2016.

S. J. Borgwardt, P. Allen, S. Bhattacharyya, P. Fusar-poli, J. A. Crippa et al., , 2008.

, Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol : effects during response inhibition, Biological psychiatry, vol.64, issue.11, p.137

S. Bhattacharyya, P. D. Morrison, P. Fusar-poli, R. Martin-santos, S. Borgwardt et al., Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology, Neuropsychopharmacology, vol.35, issue.3, pp.764-774, 2010.

H. H. Van-hell, G. Jager, M. G. Bossong, A. Brouwer, J. M. Jansma et al., , 2012.

, Psychopharmacology, vol.219, issue.4, pp.981-990

M. A. Bloomfield, C. J. Morgan, S. Kapur, H. V. Curran, and O. D. Howes, The link between dopamine function and apathy in cannabis users : an [18F]-DOPA PET imaging study, 2014.

, Psychopharmacology, vol.231, issue.11, pp.2251-2259

N. D. Volkow, G. J. Wang, F. Telang, J. S. Fowler, D. Alexoff et al., Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity, Proceedings of the National Academy of Sciences of the United States of America, vol.111, pp.3149-3156, 2014.

E. Van-de-giessen, J. J. Weinstein, C. M. Cassidy, M. Haney, Z. Dong et al., Deficits in striatal dopamine release in cannabis dependence, Molecular psychiatry, vol.22, issue.1, pp.68-75, 2017.

S. Spiga, A. Lintas, M. Migliore, and M. Diana, Altered architecture and functional consequences of the mesolithic dopamine system in cannabis dependence, Addiction biology, vol.15, pp.266-276, 2010.

B. Kolb, G. Gordy, C. L. Limebeer, and L. A. Parker, Chronic treatment with Delta-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats, Synapse, vol.60, pp.429-436, 2006.

A. Bonnin, R. De-miguel, M. L. Hernandez, J. A. Ramos, and J. J. Fernandez-ruiz, The prenatal exposure to delta-9-tetrahydrocannabinol affects the gene expression and the activity of tyrosine hydroxylase during early brain development, Life sciences, vol.56, pp.2177-2184, 1995.

J. A. Dinieri, X. Wang, H. Szutirisz, S. M. Spano, J. Kaur et al., Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring, Biological psychiatry, vol.70, issue.8, pp.763-769, 2011.

L. Garcia-gil, R. De-miguel, R. M. Munoz, M. Cebeira, M. A. Villanua et al., , 1997.

, tetrahydocannabinol exposure alters the responsiveness of hypothalamic dopaminergic neurons ti dopamine-acting drugs in adults rats, Neurotoxicology and teratology, vol.19, issue.9, p.138

D. J. Mokler, S. E. Robinson, J. H. Johnson, J. S. Hong, and J. A. Rosecrans, Neonatal administration of delta-9-tetrahydrocannabinol (THC) alters the neurochemical response to stress in the adult Fischer-344 rat, Neurotoxicology and teratology, vol.9, pp.321-327, 1987.

L. N. Voruganti, P. Slomka, P. Zabel, A. Mattar, and A. G. Awad, Cannabis induced dopamine release : an in-vivo SPECT study, Psychiatry research, vol.107, issue.3, pp.173-177, 2001.

J. L. Thompson, N. Urban, M. Slifstein, X. Xu, L. S. Kegeles et al., Striatal dopamine release in schizophrenia comorbid with substance dependence, Molecular psychiatry, vol.18, issue.8, pp.909-915, 2013.

F. M. Leweke, D. Piomelli, F. Pahlisch, D. Muhl, C. W. Gerth et al., , 2012.

, Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia, Translational psychiatry, vol.2, p.94

N. Laaris, C. H. Good, and C. R. Lupica, Delta9-tetrahydrocannabinol is full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus, Neuropharmacology, vol.59, issue.1-2, pp.121-127, 2010.

, Amine Benyamina et le Congrès de psychiatrie et de neurologie de langue française, Addictions et comorbidités. Edition Dunod, 1926.

, Amine Benyamina et le Congrès de psychiatrie et de neurologie de langue française, Addictions et comorbidités. Edition Dunod, 1925.

, Amine Benyamina et le Congrès de psychiatrie et de neurologie de langue française, Addictions et comorbidités. Edition Dunod, p.27, 2014.

C. Leroy, L. Karila, J. L. Martinot, M. Lukasiewicz, E. Duchesnay et al., , 2012.

, Striatal ans extrastriatal dopamine transporter in cannabis and tobacco addiction : a highresolution PET study, Addiction biology, vol.17, issue.6, pp.981-990

L. J. Vanschuren and R. C. Pierce, Sensitization processes in drug addiction, Current topics in behavioral neurosciences, vol.3, pp.179-195, 2010.

G. F. Koob, L. Moal, and M. , Neurobiological mechanisms for opponent motivational processes in addiction, Philosophical transactions of the Royal Society of London. Serie B, biological sciences, vol.363, pp.3113-3123, 1507.

, Amine Benyamina et le Congrès de psychiatrie et de neurologie de langue française, Addictions et comorbidités. Edition Dunod, p.58, 2014.

M. Reynaud and A. Benyamina,

M. T. Tsuang, M. J. Lyons, J. M. Meyer, T. Doyle, S. A. Eisen et al., Cooccurence of abuse of different drugs in men : the role of drug-specific and shared vulnerabilities, Archives of general psychiatry, vol.55, issue.11, pp.967-972, 1998.

K. S. Kendler and C. A. Prescott, Cannabis use, abuse, and dependence in a population-based sample of female twins. The American journal of psychiatry, vol.155, pp.1016-1022, 1998.

M. Reynaud and A. Benyamina, , p.14, 2009.

M. T. Lynskey, A. C. Heath, E. C. Nelson, K. K. Bucholz, P. A. Madden et al., , 2002.

, Genetic and environmental contributions to cannabis dependence in a national young adult twin sample, Psychological medicine, vol.32, issue.2, pp.195-207

, Amine Benyamina et le Congrès de psychiatrie et de neurologie de langue française, Addictions et comorbidités. Edition Dunod, p.59, 2014.

C. Demily and N. Franck, Schizophrénie : diagnostic et prise en charge, 2013.

C. Demily and N. Franck, Schizophrénie : diagnostic et prise en charge, pp.14-15, 2013.

A. Caspi, T. E. Moffitt, M. Cannon, J. Mcclay, R. Murray et al., , 2005.

, Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene : longitudinal evidence of a gene X environment interaction, Biological Psychiatry, vol.57, issue.10, pp.1117-1127

D. H. Nieman, S. Dragt, E. Van-duin, N. Denneman, J. M. Overbeek et al., COMT Val(158)Met genotype and cannabis use in people with an At Risk Mental State for psychosis : exploring gene x environment interactions, Schizophrenia research, vol.174, issue.1-3, pp.24-28, 2016.

S. Leroy, N. Griffon, M. C. Bourdel, J. P. Olié, M. F. Poirier et al., Schizophrenia and the cannabinoid receptor type 1 (CB1) : association study using a single-base polymorphism in coding exon 1, American journal of medical genetics, vol.105, issue.8, pp.749-752, 2001.

I. Chavarria-siles, J. Contreras-rojas, E. Hare, C. Walss-bass, P. Quezada et al., Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia. American journal of medical genetics, Part B : Neuropsychiatric genetics : the official publication of the International Society of Psychiatrics Genetics, vol.147, pp.279-284, 2008.

S. J. Tsai, Y. C. Wang, and C. J. Hong, Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia, Psychiatric genetics, vol.10, issue.3, p.140, 2000.

C. Demily and N. Franck, Schizophrénie : diagnostic et prise en charge, 2013.

R. Honea, T. J. Crow, D. Passingham, and C. E. Mackey, Regional deficits in brain volume in schizophrenia : a meta-analysis of voxel-based morphometry studies. The American journal of psychiatry, vol.162, pp.2233-2245, 2005.

G. Barbalat and N. Et-franck, Imagerie cérébrale et schizophrénie, EMC Psychiatrie, vol.9, issue.3, pp.37-285, 2012.

C. Demily and N. Franck, Schizophrénie : diagnostic et prise en charge, 2013.

S. S. Bangalore, K. M. Prasad, D. M. Montrose, D. D. Goradia, V. A. Diwadkar et al., Cannabis use and brain structural alterations in first episode schizophrenia-a region of interest, voxel based morphometric study, Schizophrenia research, vol.99, issue.1-3, pp.1-6, 2008.

P. R. Szeszko, D. G. Robinson, S. Sevy, S. Kumra, C. I. Rupp et al., Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia. The British journal of psychiatry : the journal of mental science, vol.190, pp.230-236, 2007.

G. C. Chan, T. R. Hinds, S. Impey, and D. R. Storm, Hippocampal neurotoxicity of Delta9-tetrahydrocannabinol, The Journal of neuroscience : the official journal of the Society for Neuroscience, vol.18, issue.14, pp.5322-5332, 1998.

R. I. Block, D. S. O'leary, J. C. Ehrhardt, J. C. Augustinack, M. M. Ghoneim et al., Effects of frequent marijuana use on brain tissue volume and composition, Neuroreport, vol.11, issue.3, pp.491-496, 2000.

G. K. Tzilos, C. B. Cintron, J. B. Wood, N. S. Simpson, A. D. Young et al., Lack of hippocampal volume change in long-term heavy cannabis users, The American journal on addictions, vol.14, issue.1, pp.64-72, 2005.

J. A. Matochik, D. A. Eldreth, J. L. Cadet, and K. I. Bolla, Altered brain tissue composition in heavy marijuana users. Drug and alcohol dependence, vol.77, pp.23-30, 2005.

R. A. Chambers, J. H. Krystal, and D. W. Self, A neurobiological basis for substance abuse comorbidity in schizophrenia, Biological psychiatry, vol.50, issue.2, pp.71-83, 2001.

M. J. Smith, D. J. Cobia, L. Wang, K. I. Alpert, W. J. Cronenwett et al., , 2013.

, Cananbis-related working memory deficits and associated subcortical morphological differences in healthy individuals and schizophrenia subjects, Schizophrenia bulletin, vol.40, issue.2, p.141